Table: Taiko Pharmaceutical -2021 group results

Taiko Pharmaceutical

18/02/2022 06:30

Feb 18 (Reuters)- 
          Taiko Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                    Year ended      Year ended       Year to       NEXT   
                 Dec 31, 2021    Dec 31, 2020   Dec 31, 2022     YEAR     
                    LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS          RESULTS       FORECAST    H1 FORECAST 
  Sales             11.30            17.58                                
  Operating       loss 4.95           5.65                                
  Recurring       loss 6.13           5.45                                
  Net
  Net             loss 9.59           3.85                                
  EPS          loss 220.52 yen     89.18 yen                              
  EPS Diluted                      88.82 yen                              
  Ann Div            NIL           25.00 yen                              
  -Q2 Div            NIL           7.00 yen                               
  -Q4 Div            NIL           18.00 yen                              
  
  NOTE - Taiko Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T